Stephen From, President and Chief Executive Officer
Stephen has served as our President, Chief Executive Officer, and director since October 2005. Prior to joining EyeGate, he was the Chief Financial Officer at Centelion SAS, an independent biotechnology subsidiary of Sanofi-Aventis. Previously, Mr. From spent several years as an investment banker specializing in the biotechnology and medical device sectors as Director in the Global Healthcare Corporate and Investment Banking Group and Head of European Life Sciences for Bank of America Securities. Mr. From holds a BSc from the University of Western Ontario, an accounting diploma from Wilfred Laurier University and has qualified as a Chartered Accountant in Ontario, Canada.
Michael Raizman, MD, Consulting Chief Medical Officer
Michael is a specialist in laser vision correction and treatment of the cornea with Ophthalmic Consultants of Boston. He is also an Associate Professor of Ophthalmology at Tufts University School of Medicine where he has directed the Corneal Fellowship Training Program. Dr. Raizman has also served on the full-time faculty of Harvard Medical School. He is on the editorial board of the Archives of Ophthalmology and Therapeutic Updates in Ophthalmology, and is author of over 60 medical articles. Dr. Raizman holds a MD from the University of Michigan Medical School.
Michael A. Patane, PhD, Consulting Chief Scientific Officer
Michael was most recently an Executive Director in Global Discovery Chemistry at Novartis, where he was responsible for the infectious disease and ophthalmology drug discovery units. Previously, he was Director of Medicinal Chemistry at Millennium Pharmaceuticals where he led oncology and metabolic diseases drug discovery. Michael holds a BS in chemistry from Fordham University, a PhD in synthetic organic chemistry from USC, and completed a Post-Doctoral appointment at The Scripps Research Institute.
Michael Manzo, Vice President of Engineering
Michael joined EyeGate in October 2006 and has served in his current role since 2008. Mr. Manzo has over 30 years of experience in product development and manufacturing in the medical device industry. Prior to joining Eyegate, Mr. Manzo was President and Chief Operating Officer (2002 – 2006) at Jenline Industries, Ltd., which is now part of Helix Medical, LLC. He has also worked with a number of start-up companies in areas such as cardiology, radiology, urology and laproscopic surgery. Mr. Manzo holds an MBA from Suffolk University and a Bachelor of Science Degree in engineering from University of Massachusetts, Lowell.
Lisa Brandano, Director of Clinical Operations
Lisa joined the Company from Cato Research (CATO) where she served as Assistant Managing Director of their Boston Office and Director of Clinical Trial Operations. She was involved in the oversight and facilitation of global clinical operations. Her Clinical Research experience includes monitoring and project management of various neurology, hematology, and cardiovascular gene therapy studies spanning Phases 1, 2, and 3. Prior to this she held clinical research coordinator and laboratory science roles at Beth Israel Deaconess Medical Center in Boston. She holds a BS in biology from Emmanuel College, and since 2003, she has been a certified clinical research associate (CRA) with the Association of Clinical Research Professionals (ACRP).